Assessment of Heart Rate Variability for Predicting Obstructive Sleep Apnea in Patients With Hypertension
Recruiting
Observational Study
Obstructive Sleep Apnea
Hypertension
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 65
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- Kaohsiung Armed Forces General Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to investigate the relationship between hypertension and obstructive sleep apnea (OSA) using heart rate variability (HRV) as a non-invasive biomarker of autonomic nervous system function.
Hypertensive patients at high risk for OSA will undergo 24-hour Holter electrocardiogram monitoring to assess HRV parameters, along with overnight polysomnography (PSG) to determine OSA severity.…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 to 65 years
* Diagnosed hypertension or resistant hypertension
* STOP-Bang score ≥3 indicating high risk of obstructive sleep apnea
* Willing and able to provide informed consent
Exclusion Criteria:
* Refusal to undergo HRV monitoring or polysomnography
* Unstable med…
Contacts